A5 Correlation

Table A5.1: Histology performed within 6 months of a primary screening test, by prior LBC test result, participants aged 25–74 screened in 2023

Prior LBC test result

Negative histology

Low-grade 
 histology

High-grade 
 histology

Cancer histology

Negative

16.4

37.2

9.5

4.8

Low-grade

5.2

22.4

11.5

2.2

High-grade+

2.7

17.2

68.0

69.7

Note: Histology does not equal 100% as cases where LBC was not performed are included in calculations but excluded from this figure. Prior LBC of high-grade+ includes high-grade abnormalities and cervical cancer.

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A5.2: Proportion of high-grade or glandular LBC tests followed by high-grade cervical abnormality or cervical cancer histology within 6 months, participants aged 25–74, 2018 to 2023

Year

Number of high-grade LBC test results

Number followed by high-grade cervical histology within 6 months 

Proportion (%)

2018

9,124

6,095

66.8

2019

7,820

5,264

67.3

2020

4,683

3,275

69.9

2021

3,827

2,808

73.4

2022

2,754

1,971

71.6

2023

2,974

2,103

70.7

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Previous page
Next page